Quest Diagnostics Reports Second Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Quest Diagnostics (DGX) Reports In-Line Q2 EPS, Slight Revenue Miss; Narrows FY18 EPS Outlook, Lowers FY18 Revenue Mid-Point Guidance
July 24, 2018 6:49 AM EDTQuest Diagnostics (NYSE: DGX) reported Q2 EPS of $1.75, in-line with the analyst estimate of $1.75. Revenue for the quarter came in at $1.91 billion versus the consensus estimate of $1.95 billion.
"Once again, we grew revenues and delivered strong earnings growth in the second quarter,\" said... More
